Mihran H. Shirinian
Distinguished in Acute Mountain Sickness

Dr. Mihran H. Shirinian

Hematology
CommonSpirit Health
Comprehensive Oncology Hematology Center
1505 Wilson Terr, Ste 340, 
Glendale, CA 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Distinguished in Acute Mountain Sickness
CommonSpirit Health
Comprehensive Oncology Hematology Center
1505 Wilson Terr, Ste 340, 
Glendale, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

To provide state of the art medical care for our patients in a friendly, and compassionate setting.

Dr. Shirinian is rated as a Distinguished provider by MediFind in the treatment of Acute Mountain Sickness. His top areas of expertise are Acute Erythroid Leukemia (AEL), Colorectal Cancer, Small Cell Lung Cancer (SCLC), and Lung Adenocarcinoma.

His clinical research consists of co-authoring 1 peer reviewed article and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Cairo University
Specialties
Hematology
Licenses
Internal Medicine in CA
Board Certifications
Internal Medicine (Sub: Medical Oncology)
Internal Medicine
Hospital Affiliations
Keck Hospital Of USC
Glendale Adventist Medical Center
Languages Spoken
English
Arabic
Armenian
French
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
LA Care
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

Comprehensive Oncology Hematology Center
1505 Wilson Terr, Ste 340, Glendale, CA 91206
Call: 818-543-7574

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 1/2, Open-Label, Multi-Center, First-in-Human Study of the Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of TPX-0005 in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements (TRIDENT-1)
A Phase 1/2, Open-Label, Multi-Center, First-in-Human Study of the Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of TPX-0005 in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements (TRIDENT-1)
Enrollment Status: Recruiting
Publish Date: July 10, 2025
Intervention Type: Drug
Study Drug: Repotrectinib
Study Phase: Phase 1/Phase 2
QUILT-3.055: A Phase IIb, Multicohort, Open-Label Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With PD-1/PD-L1 Immune Checkpoint Inhibitors
QUILT-3.055: A Phase IIb, Multicohort, Open-Label Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With PD-1/PD-L1 Immune Checkpoint Inhibitors
Enrollment Status: Active_not_recruiting
Publish Date: October 17, 2025
Intervention Type: Drug
Study Drugs: N-803, Pembrolizumab, Nivolumab, Atezolizumab, Avelumab, Durvalumab, PD-L1 t-haNK
Study Phase: Phase 2
Phase 3, Open-Label, 4-Cohort Study of Nogapendekin Alfa Inbakicept in Combination With Current Standard of Care as First-Line Treatment for Patients With Advanced or Metastatic Non-Small Cell Lung Cancer
Phase 3, Open-Label, 4-Cohort Study of Nogapendekin Alfa Inbakicept in Combination With Current Standard of Care as First-Line Treatment for Patients With Advanced or Metastatic Non-Small Cell Lung Cancer
Enrollment Status: Active_not_recruiting
Publish Date: October 16, 2025
Intervention Type: Drug
Study Drugs: N-803+Pembrolizumab, N-803+Carboplatin+Nab-paclitaxel+Pembrolizumab, N-803+Cisplatin or Carboplatin+Pembrolizumab+Pemetrexed, Pembrolizumab, Carboplatin+Nab-paclitaxel or Paclitaxel+Pembrolizumab, Cisplatin or Carboplatin+Pembrolizumab+Pemetrexed
Study Phase: Phase 3
Elacestrant Monotherapy vs. Standard of Care for the Treatment of Patients With ER+/HER2- Advanced Breast Cancer Following CDK4/6 Inhibitor Therapy: A Phase 3 Randomized, Open-label, Active-controlled, Multicenter Trial
Elacestrant Monotherapy vs. Standard of Care for the Treatment of Patients With ER+/HER2- Advanced Breast Cancer Following CDK4/6 Inhibitor Therapy: A Phase 3 Randomized, Open-label, Active-controlled, Multicenter Trial
Enrollment Status: Completed
Publish Date: September 15, 2025
Intervention Type: Drug
Study Drugs: Elacestrant, Standard of Care
Study Phase: Phase 3
View 3 Less Clinical Trials

1 Total Publications

Downstaging after preoperative chemoradiation for locally advanced rectal cancer is associated with better survival than pathologic stage 0-1 disease treated with upfront surgery.
Downstaging after preoperative chemoradiation for locally advanced rectal cancer is associated with better survival than pathologic stage 0-1 disease treated with upfront surgery.
Journal: International journal of colorectal disease
Published: December 24, 2023
Similar Doctors
Advanced in Acute Mountain Sickness
Dr. Kalust Ucar
Hematology
Advanced in Acute Mountain Sickness
Dr. Kalust Ucar
Hematology

Kalust Ucar, MD Private Practice

222 W Eulalia St, Ste 100B, 
Glendale, CA 
 (2.2 miles away)
818-637-7611
Languages Spoken:
English, Armenian, French, Portuguese, Spanish
See accepted insurances
Offers Telehealth

Kalust Ucar is a Hematologist in Glendale, California. Dr. Ucar is rated as a Distinguished provider by MediFind in the treatment of Acute Mountain Sickness. His top areas of expertise are Familial Colorectal Cancer, Paget Disease of the Breast, Iron Deficiency Anemia, and Childhood Iron Deficiency Anemia.

Distinguished in Acute Mountain Sickness
Dr. Greg R. Angstreich
Hematology Oncology | Hematology | Oncology
Distinguished in Acute Mountain Sickness
Dr. Greg R. Angstreich
Hematology Oncology | Hematology | Oncology

USC Care Medical Group Inc

1520 San Pablo St, Fl 4, 
Los Angeles, CA 
 (6.2 miles away)
800-872-2273
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Greg Angstreich is a Hematologist Oncology specialist and a Hematologist in Los Angeles, California. Dr. Angstreich is rated as a Distinguished provider by MediFind in the treatment of Acute Mountain Sickness. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Richter Syndrome, B-Cell Lymphoma, and Chronic B-Cell Leukemia (CBCL).

Distinguished in Acute Mountain Sickness
Dr. David M. Hoffman
Hematology Oncology | Hematology | Oncology
Distinguished in Acute Mountain Sickness
Dr. David M. Hoffman
Hematology Oncology | Hematology | Oncology

Cedars-Sinai Medical Care Foundation

8723 Alden Dr, Suite 260, 
Los Angeles, CA 
 (10.1 miles away)
310-248-8299
Languages Spoken:
English
See accepted insurances
Offers Telehealth

David Hoffman is a Hematologist Oncology specialist and a Hematologist in Los Angeles, California. Dr. Hoffman is rated as a Distinguished provider by MediFind in the treatment of Acute Mountain Sickness. His top areas of expertise are Myelodysplastic Syndrome (MDS), Iron Deficiency Anemia, Lung Adenocarcinoma, and Small Cell Lung Cancer (SCLC).

VIEW MORE ACUTE MOUNTAIN SICKNESS DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Shirinian's expertise for a condition
ConditionClose
    • Distinguished
    • Acute Erythroid Leukemia (AEL)
      Dr. Shirinian is
      Distinguished
      . Learn about Acute Erythroid Leukemia (AEL).
      See more Acute Erythroid Leukemia (AEL) experts
    • Acute Mountain Sickness
      Dr. Shirinian is
      Distinguished
      . Learn about Acute Mountain Sickness.
      See more Acute Mountain Sickness experts
    • Agranulocytosis
      Dr. Shirinian is
      Distinguished
      . Learn about Agranulocytosis.
      See more Agranulocytosis experts
    • ALK-Positive Non-Small Cell Lung Cancer
      Dr. Shirinian is
      Distinguished
      . Learn about ALK-Positive Non-Small Cell Lung Cancer.
      See more ALK-Positive Non-Small Cell Lung Cancer experts
    • Anemia
      Dr. Shirinian is
      Distinguished
      . Learn about Anemia.
      See more Anemia experts
    • Angiosarcoma
      Dr. Shirinian is
      Distinguished
      . Learn about Angiosarcoma.
      See more Angiosarcoma experts
    View All 30 Distinguished Conditions
    • Advanced
    • Adult Soft Tissue Sarcoma
      Dr. Shirinian is
      Advanced
      . Learn about Adult Soft Tissue Sarcoma.
      See more Adult Soft Tissue Sarcoma experts
    • Blood Clots
      Dr. Shirinian is
      Advanced
      . Learn about Blood Clots.
      See more Blood Clots experts
    • Chronic B-Cell Leukemia (CBCL)
      Dr. Shirinian is
      Advanced
      . Learn about Chronic B-Cell Leukemia (CBCL).
      See more Chronic B-Cell Leukemia (CBCL) experts
    • Chronic Lymphocytic Leukemia (CLL)
      Dr. Shirinian is
      Advanced
      . Learn about Chronic Lymphocytic Leukemia (CLL).
      See more Chronic Lymphocytic Leukemia (CLL) experts
    • Congenital Antithrombin 3 Deficiency
      Dr. Shirinian is
      Advanced
      . Learn about Congenital Antithrombin 3 Deficiency.
      See more Congenital Antithrombin 3 Deficiency experts
    • Deep Vein Thrombosis
      Dr. Shirinian is
      Advanced
      . Learn about Deep Vein Thrombosis.
      See more Deep Vein Thrombosis experts
    View All 41 Advanced Conditions
    • Experienced
    • Acinic Cell Carcinoma of Salivary Glands
      Dr. Shirinian is
      Experienced
      . Learn about Acinic Cell Carcinoma of Salivary Glands.
      See more Acinic Cell Carcinoma of Salivary Glands experts
    • Acute Myeloblastic Leukemia with Maturation
      Dr. Shirinian is
      Experienced
      . Learn about Acute Myeloblastic Leukemia with Maturation.
      See more Acute Myeloblastic Leukemia with Maturation experts
    • Acute Myeloblastic Leukemia without Maturation
      Dr. Shirinian is
      Experienced
      . Learn about Acute Myeloblastic Leukemia without Maturation.
      See more Acute Myeloblastic Leukemia without Maturation experts
    • Acute Myeloid Leukemia (AML)
      Dr. Shirinian is
      Experienced
      . Learn about Acute Myeloid Leukemia (AML).
      See more Acute Myeloid Leukemia (AML) experts
    • Adult Immune Thrombocytopenia
      Dr. Shirinian is
      Experienced
      . Learn about Adult Immune Thrombocytopenia.
      See more Adult Immune Thrombocytopenia experts
    • Alveolar Soft Part Sarcoma
      Dr. Shirinian is
      Experienced
      . Learn about Alveolar Soft Part Sarcoma.
      See more Alveolar Soft Part Sarcoma experts
    View All 130 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.